SPIN1 and liposarcoma: Since the F141A mutation in tudor-like domain 2, which blocks SPIN1 chromatin binding, interferes with SPIN1-controlled liposarcoma cell proliferation and survival, targeting the SPIN1/H3K4me3 pocket with small molecule inhibitors might be an interesting alternative therapeutic option for cancer treatment.